|
Volumn 495, Issue , 2001, Pages 343-347
|
Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer
a b a a a a b c c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
C TYPE LECTIN RECEPTOR LIGAND;
DENDRIMER;
LECTIN RECEPTOR;
LIGAND;
UNCLASSIFIED DRUG;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
COLON CARCINOMA;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
EXPERIMENTAL MODEL;
EXPERIMENTAL NEOPLASM;
HUMAN;
IN VIVO STUDY;
MELANOMA B16;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TUMOR IMMUNITY;
ANIMALS;
ANTIGENS, SURFACE;
COLORECTAL NEOPLASMS;
GLYCOCONJUGATES;
GLYCOSYLATION;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
LECTINS;
LECTINS, C-TYPE;
LIGANDS;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
RATS;
RECEPTORS, MITOGEN;
|
EID: 18244364846
PISSN: 00652598
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-0685-0_48 Document Type: Article |
Times cited : (25)
|
References (4)
|